BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
      • Artificial intelligence
    • Coronavirus
    • Israel
    • IVDs on the rise
    • Radiopharmaceuticals
    • Rise of obesity
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 11, 2023
Home » RSS feeds
Email
Tweet

RSS feeds

Get topic alerts directly to your email inbox

Here’s an easy way to receive the latest news related to your topic(s) of choice as soon as the articles are published.

1. Copy a url for a topic from the list below.

2. In Outlook, right-click the RSS feeds folder and choose Add a New RSS Feed.

rss feed outlook.jpg

3. Paste the url.

4. Choose Add > OK.

5. Suggestion: Create a subfolder for your topic and an associated rule so they alerts are moved directly into your folder of choice.

Alternately, you may use the same links in any RSS reader application such as Feedly or Innoreader.

Topics

Aesthetics

https://www.bioworld.com/rss/topic/237-aesthetics


Analysis and data insight

https://www.bioworld.com/rss/topic/109-analysis-and-data-insight


Anesthesiology

https://www.bioworld.com/rss/topic/238-anesthesiology


Artificial intelligence

https://www.bioworld.com/rss/5


Asia-Pacific — Includes Asia-Pacific, Australia, China, Japan

https://www.bioworld.com/rss/23


Australia — Includes Australia, TGA

https://www.bioworld.com/rss/26


Biomarkers

https://www.bioworld.com/rss/topic/543-biomarkers


Briefs — Includes appointments and advancements, briefs, deals and M&A, earnings, in the clinic, other news to note, post market, preclinical, products regulatory, products clinical, regulatory actions, regulatory front, stock

https://www.bioworld.com/rss/11


Canada — Includes Canada, Health Canada

https://www.bioworld.com/rss/27


Cancer — Includes cancer, oncology

https://www.bioworld.com/rss/15


CAR T — Includes CAR T (Cell therapy), CAR T (Gene therapy), CAR T (Immunotherapy)

https://www.bioworld.com/rss/8


Cardiovascular

https://www.bioworld.com/rss/topic/240-cardiovascular


Cell therapy

https://www.bioworld.com/rss/6


China — Includes China, NMPA

https://www.bioworld.com/rss/28


Clinical — Clinical, in the clinic, products clinical

https://www.bioworld.com/rss/12


Coronavirus

https://www.bioworld.com/rss/topic/517-coronavirus


Deals and M&A — Includes acquisition, asset purchase, collaboration, co-promotion, deals and M&A, deals and M&A (briefs), development, distribution, equity option, government supply contract, grant, joint venture, license, merger, non-profit, research, research only, reverse merger, royalty buyout, service agreement, settlement, spinout, supply only

https://www.bioworld.com/rss/14


Dental

https://www.bioworld.com/rss/topic/241-dental


Dermatologic

https://www.bioworld.com/rss/topic/242-dermatologic


Diagnostics — Includes artificial intelligence (Diagnostics), biopsy, diagnostics, electrocardiogram, genomics, imaging, liquid biopsy, monitoring, point-of-care

https://www.bioworld.com/rss/21


Digital health — Includes algorithm, artificial intelligence, cloud-based platform, cybersecurity, database, digital health, electronic health record, mobile/smartphone app, SAAS, SAMD, software, telehealth

https://www.bioworld.com/rss/22


Drug design, drug delivery and technologies

https://www.bioworld.com/rss/topic/544-drug-design-drug-delivery-and-technologies


Drug resistance

https://www.bioworld.com/rss/topic/117-drug-resistance


Drugs — Includes antibiotic, antibody, antibody-drug conjugate, antigen, antisense, biosimilar, bispecific antibody, CAR T, cell therapy, drugs, enzyme, gene therapy, generic, immuno-oncology, microbiome, monoclonal antibody, nanotech, natural, oncolytic, peptide, plasma, protein, RNAi, small molecule, vaccine

https://www.bioworld.com/rss/18


Ear, nose and throat

https://www.bioworld.com/rss/topic/245-ear-nose-and-throat


EMA

https://www.bioworld.com/rss/topic/430-ema


Endocrine/metabolic — Includes diabetes, endocrine/metabolic, obesity

https://www.bioworld.com/rss/16


Europe — Includes EMA, Europe, MHRA

https://www.bioworld.com/rss/29


FDA

https://www.bioworld.com/rss/topic/433-fda


Financings — Includes American depositary shares, at-the-market offering, bought deal offering, credit facility, investment, financings, follow-on, IPO, grant, loan, mezzanine, notes offering, PIPE (private investment of public equity), private, private placement, public, registered direct offering, seed, series A, series B, series C, series D, series E, series F, series G, share issue, warrant exercise

https://www.bioworld.com/rss/19


Gastrointestinal

https://www.bioworld.com/rss/topic/247-gastrointestinal


Gene therapy

https://www.bioworld.com/rss/7


Genetic/congenital

https://www.bioworld.com/rss/topic/548-genetic-congenital


Genitourinary/sexual function

https://www.bioworld.com/rss/topic/248-genitourinary-sexual-function


Health Canada

https://www.bioworld.com/rss/topic/439-health-canada


Hematologic

https://www.bioworld.com/rss/topic/249-hematologic


HIV/AIDS

https://www.bioworld.com/rss/topic/542-hiv-aids


Immune

https://www.bioworld.com/rss/topic/250-immune


Immuno-oncology

https://www.bioworld.com/rss/topic/280-immuno-oncology


Infection

https://www.bioworld.com/rss/topic/251-infection


Inflammatory

https://www.bioworld.com/rss/topic/252-inflammatory


Japan

https://www.bioworld.com/rss/30


Latin America

https://www.bioworld.com/rss/topic/397-latin-america


Medical devices and technologies — Includes sub-topics ranging from artificial intelligence to robotic surgery

https://www.bioworld.com/rss/20


Ministry of Health, Labour and Welfare

https://www.bioworld.com/rss/topic/460-mhlw


Medicines and Healthcare products Regulatory Agency

https://www.bioworld.com/rss/topic/458-mhra


Microbiome

https://www.bioworld.com/rss/9


Middle East North Africa

https://www.bioworld.com/rss/topic/398-middle-east-north-africa


Musculoskeletal

https://www.bioworld.com/rss/topic/253-musculoskeletal


Neonatal/pediatrics

https://www.bioworld.com/rss/topic/254-neonatal-pediatrics


Nephrology

https://www.bioworld.com/rss/topic/255-nephrology


Neurology/psychiatric

https://www.bioworld.com/rss/topic/256-neurology-psychiatric


New compound

https://www.bioworld.com/rss/topic/546-new-compound


Newco news — Feature articles on newly emerging companies

https://www.bioworld.com/rss/topic/391-newco-news


National Medical Products Administration

https://www.bioworld.com/rss/topic/556-nmpa


Obstetrics

https://www.bioworld.com/rss/topic/258-obstetrics


Ocular — Includes ocular, ophthalmic

https://www.bioworld.com/rss/17


Omics — Includes genomics, GWAS, metabolomics, omics, proteomics

https://www.bioworld.com/rss/10


Orthopedics (medtech)

https://www.bioworld.com/rss/topic/262-orthopedics


Regulatory — Includes coverage of top regulatory news from global regulatory agencies

https://www.bioworld.com/rss/24


Respiratory

https://www.bioworld.com/rss/topic/263-respiratory


Substance use and poisoning

https://www.bioworld.com/rss/topic/545-substance-use-and-poisoning


Therapeutic Goods Administration

https://www.bioworld.com/rss/topic/488-tga


Toxicity/intoxication

https://www.bioworld.com/rss/topic/264-toxicity-intoxication


U.S. — Includes 510(k), CDRH, Central Drugs Standard Control Organization, CMS, FDA, FTC, NIH, orange book, PDUFA, SEC, U.S.

https://www.bioworld.com/rss/31


Urology

https://www.bioworld.com/rss/topic/265-urology


Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 8, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for December 8, 2023.
  • Coronavirus, mRNA and syringe

    Off-target immune response from modified mRNA impacts future development

    BioWorld
    The Nobel Prize-winning modification that prevents the innate immune system from recognizing injected mRNA as foreign and blocking transcription of the protein it...
  • Stock chart with falling red arrow

    ‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s

    BioWorld
    For the second time this week, a contract research organization has come under fire for trial-conduct issues – criticism leveled most recently by Biovie Inc.,...
  • Feet and scale

    Waging the losing battle: Altimmune takes on challengers as Pfizer falls back

    BioWorld
    Altimmune Inc.’s peptide-based glucagon-like peptide-1/glucagon dual receptor agonist pemvidutide hiccupped in a phase I study earlier this year but has bounced...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing